These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


509 related items for PubMed ID: 12050243

  • 21. The growth hormone response to hexarelin in patients with different hypothalamic-pituitary abnormalities.
    Maghnie M, Spica-Russotto V, Cappa M, Autelli M, Tinelli C, Civolani P, Deghenghi R, Severi F, Loche S.
    J Clin Endocrinol Metab; 1998 Nov; 83(11):3886-9. PubMed ID: 9814463
    [Abstract] [Full Text] [Related]

  • 22. GH response to GHRH combined with pyridostigmine or arginine in different conditions of low somatotrope secretion in adulthood: obesity and Cushing's syndrome in comparison with hypopituitarism.
    Procopio M, Maccario M, Savio P, Valetto MR, Aimaretti G, Grottoli S, Oleandri SE, Baffoni C, Tassone F, Arvat E, Camanni F, Ghigo E.
    Panminerva Med; 1998 Mar; 40(1):13-7. PubMed ID: 9573747
    [Abstract] [Full Text] [Related]

  • 23. Reproducibility of the growth hormone response to stimulation with growth hormone-releasing hormone plus arginine during lifespan.
    Valetto MR, Bellone J, Baffoni C, Savio P, Aimaretti G, Gianotti L, Arvat E, Camanni F, Ghigo E.
    Eur J Endocrinol; 1996 Nov; 135(5):568-72. PubMed ID: 8980159
    [Abstract] [Full Text] [Related]

  • 24. Gender has to be taken into account in diagnosing adult growth hormone deficiency by the GHRH plus arginine test.
    Markkanen HM, Pekkarinen T, Hämäläinen E, Välimäki MJ, Alfthan H, Stenman UH.
    Growth Horm IGF Res; 2017 Aug; 35():52-56. PubMed ID: 28755537
    [Abstract] [Full Text] [Related]

  • 25. Reassessment of the growth hormone status in young adults with childhood-onset growth hormone deficiency: reappraisal of insulin tolerance testing.
    Secco A, di Iorgi N, Napoli F, Calandra E, Calcagno A, Ghezzi M, Frassinetti C, Fratangeli N, Parodi S, Benassai M, Leitner Y, Gastaldi R, Lorini R, Maghnie M, Radetti G.
    J Clin Endocrinol Metab; 2009 Nov; 94(11):4195-204. PubMed ID: 19837937
    [Abstract] [Full Text] [Related]

  • 26. Changing patterns of the adult growth hormone deficiency diagnosis documented in a decade-long global surveillance database.
    Webb SM, Strasburger CJ, Mo D, Hartman ML, Melmed S, Jung H, Blum WF, Attanasio AF, HypoCCS International Advisory Board.
    J Clin Endocrinol Metab; 2009 Feb; 94(2):392-9. PubMed ID: 19001512
    [Abstract] [Full Text] [Related]

  • 27. The cut-off limits of the GH response to GH-releasing hormone-arginine test related to body mass index.
    Corneli G, Di Somma C, Baldelli R, Rovere S, Gasco V, Croce CG, Grottoli S, Maccario M, Colao A, Lombardi G, Ghigo E, Camanni F, Aimaretti G.
    Eur J Endocrinol; 2005 Aug; 153(2):257-64. PubMed ID: 16061832
    [Abstract] [Full Text] [Related]

  • 28. Re-assessment of growth hormone secretion in young adult patients with childhood-onset growth hormone deficiency.
    Donaubauer J, Kiess W, Kratzsch J, Nowak T, Steinkamp H, Willgerodt H, Keller E.
    Clin Endocrinol (Oxf); 2003 Apr; 58(4):456-63. PubMed ID: 12641629
    [Abstract] [Full Text] [Related]

  • 29. Different degrees of GH deficiency evidenced by GHRH+arginine test and IGF-I levels in adults with pituritary disease.
    Aimaretti G, Corneli G, Di Somma C, Baldelli R, Gasco V, Rovere S, Migliaretti G, Colao A, Tamburrano G, Lombardi G, Ghigo E, Camanni F.
    J Endocrinol Invest; 2005 Mar; 28(3):247-52. PubMed ID: 15952410
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Administration of arginine plus growth hormone releasing hormone to evaluate growth hormone (GH) secretory status in children with GH deficiency.
    Keller A, Donaubauer J, Kratzsch J, Pfaeffle R, Hirsch W, Kiess W, Keller E.
    J Pediatr Endocrinol Metab; 2007 Dec; 20(12):1307-14. PubMed ID: 18341090
    [Abstract] [Full Text] [Related]

  • 32. Growth hormone (GH) deficiency (GHD) of childhood onset: reassessment of GH status and evaluation of the predictive criteria for permanent GHD in young adults.
    Maghnie M, Strigazzi C, Tinelli C, Autelli M, Cisternino M, Loche S, Severi F.
    J Clin Endocrinol Metab; 1999 Apr; 84(4):1324-8. PubMed ID: 10199773
    [Abstract] [Full Text] [Related]

  • 33. Growth hormone (GH) responses to GH-releasing hormone alone or combined with arginine in patients with adrenal incidentaloma: evidence for enhanced somatostatinergic tone.
    Terzolo M, Bossoni S, Alí A, Doga M, Reimondo G, Milani G, Peretti P, Manelli F, Angeli A, Giustina A.
    J Clin Endocrinol Metab; 2000 Mar; 85(3):1310-5. PubMed ID: 10720081
    [Abstract] [Full Text] [Related]

  • 34. GH-releasing hormone and GH-releasing peptide-6 for diagnostic testing in GH-deficient adults.
    Popovic V, Leal A, Micic D, Koppeschaar HP, Torres E, Paramo C, Obradovic S, Dieguez C, Casanueva FF.
    Lancet; 2000 Sep 30; 356(9236):1137-42. PubMed ID: 11030292
    [Abstract] [Full Text] [Related]

  • 35. Sequential administration of arginine and arginine plus GHRH to test somatotroph function in short children.
    Bellone J, Aimaretti G, Bellone S, Baffoni C, Corneli G, Origlia C, Cappa M, Ghigo E.
    J Endocrinol Invest; 2000 Feb 30; 23(2):97-101. PubMed ID: 10800762
    [Abstract] [Full Text] [Related]

  • 36. GH response to GHRH combined with pyridostigmine or arginine in different conditions of low somatotrope secretion in adulthood: obesity and Cushing's syndrome in comparison with hypopituitarism.
    Procopio M, Maccario M, Savio P, Valetto MR, Aimaretti G, Grottoli S, Oleandri SE, Baffoni C, Tassone F, Arvat E, Camanni F, Ghigo E.
    Minerva Endocrinol; 1999 Feb 30; 24(3-4):107-11. PubMed ID: 10953725
    [Abstract] [Full Text] [Related]

  • 37. Growth hormone response to hexarelin, growth hormone-releasing hormone plus pyridostigmine and arginine plus estrogen in prepubertal and early pubertal short children.
    Guzzaloni G, Grugni G, Morabito F.
    Minerva Endocrinol; 1998 Dec 30; 23(4):99-104. PubMed ID: 10361807
    [Abstract] [Full Text] [Related]

  • 38. GH secretion is impaired in patients with primary hyperparathyroidism.
    Gasperi M, Cecconi E, Grasso L, Bartalena L, Centoni R, Aimaretti G, Broglio F, Miccoli P, Marcocci C, Ghigo E, Martino E.
    J Clin Endocrinol Metab; 2002 May 30; 87(5):1961-4. PubMed ID: 11994325
    [Abstract] [Full Text] [Related]

  • 39. Characteristics of adult patients with growth hormone deficiency who underwent neurosurgery for functioning and non-functioning pituitary adenomas and craniopharyngiomas.
    Baldelli R, Bianchi A, Diacono F, Passeri M, Fusco A, Valle D, Poggi M, Terlini M, Toscano V, Tamburrano G, Pontecorvi A, Maira G, De Marinis L.
    J Endocrinol Invest; 2005 Feb 30; 28(2):157-61. PubMed ID: 15887862
    [Abstract] [Full Text] [Related]

  • 40. Effect of acute pharmacological reduction of plasma free fatty acids on growth hormone (GH) releasing hormone-induced GH secretion in obese adults with and without hypopituitarism.
    Cordido F, Fernandez T, Martinez T, Peñalva A, Peinó R, Casanueva FF, Dieguez C.
    J Clin Endocrinol Metab; 1998 Dec 30; 83(12):4350-4. PubMed ID: 9851776
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 26.